IB
VRTX icon

Intrust Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Intrust Bank’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Sell
3,808
-94
-2% -$41.7K 0.14% 108
2026
Q1 		$1.74M Buy
3,902
+429
+12% +$200K 0.14% 118
2025
Q4 		$1.57M Buy
3,473
+211
+6% +$90.9K 0.13% 116
2025
Q3 		$1.28M Sell
3,262
-541
-14% -$226K 0.11% 141
2025
Q2 		$1.69M Buy
3,803
+197
+5% +$90.8K 0.15% 108
2025
Q1 		$1.75M Buy
3,606
+231
+7% +$108K 0.17% 105
2024
Q4 		$1.36M Buy
3,375
+4
+0.1% +$1.85K 0.14% 117
2024
Q3 		$1.57M Buy
3,371
+14
+0.4% +$6.72K 0.16% 114
2024
Q2 		$1.57M Sell
3,357
-55
-2% -$23.9K 0.17% 106
2024
Q1 		$1.43M Buy
3,412
+62
+2% +$26.2K 0.15% 119
2023
Q4 		$1.36M Buy
3,350
+309
+10% +$114K 0.16% 118
2023
Q3 		$1.06M Buy
3,041
+29
+1% +$10.1K 0.13% 133
2023
Q2 		$1.06M Buy
3,012
+115
+4% +$38.7K 0.13% 141
2023
Q1 		$913K Buy
2,897
+321
+12% +$96.3K 0.12% 152
2022
Q4 		$744K Buy
2,576
+205
+9% +$62.5K 0.1% 178
2022
Q3 		$686K Buy
2,371
+202
+9% +$58.1K 0.11% 171
2022
Q2 		$611K Buy
2,169
+450
+26% +$120K 0.09% 199
2022
Q1 		$448K Buy
1,719
+798
+87% +$189K 0.06% 261
2021
Q4 		$202K Buy
+921
New +$179K 0.02% 389
2021
Q3 		– Sell
-1,324
Closed -$267K – 391
2021
Q2 		$267K Buy
1,324
+120
+10% +$25.1K 0.04% 319
2021
Q1 		$258K Sell
1,204
-69
-5% -$15.2K 0.04% 323
2020
Q4 		$301K Buy
1,273
+488
+62% +$112K 0.05% 287
2020
Q3 		$214K Buy
+785
New +$217K 0.04% 311

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Intrust Bank's VRTX Position: Q2 2026 in Review

Intrust Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 2.4% in Q2 2026, selling an estimated $41.7K and leaving 3,808 shares worth $1.89M. The position accounts for 0.14% of the portfolio, ranked #108.

Intrust Bank first reported a position in VRTX in Q3 2020 and has held it in 23 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Intrust Bank held 3,808 shares of Vertex Pharmaceuticals worth $1.89M as of Q2 2026.
  • Intrust Bank sold 94 Vertex Pharmaceuticals shares in Q2 2026, an estimated $41.7K.
  • Vertex Pharmaceuticals made up 0.14% of Intrust Bank's portfolio in Q2 2026, its #108 holding.
  • Intrust Bank first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 23 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Intrust Bank's 13F filing for Q2 2026, filed 5 Aug 2026.